More Healthcare Coverage

  • June 12, 2024

    Conn. Justices Nix Health Dept. Worker's Whistleblower Claim

    The Connecticut Supreme Court has trounced a public health official's claim that she was fired for blowing the whistle on appointees who lacked mandatory credentials, upholding her termination but also backing her simultaneous pursuit of a union grievance and an administrative complaint.

  • June 11, 2024

    Retrial Begins In NJ Fraud Case Over COVID Test Kit Deal  

    The painstaking process of jury selection got underway Tuesday in the retrial of a securities fraud case that ended with a dramatic mistrial after a juror announced in open court that he disagreed with the guilty verdict that had just been delivered by the jury forewoman.

  • June 10, 2024

    9th Circ. Says Choctaw's Dispute With CVS Must Be Arbitrated

    A Ninth Circuit panel forced the Choctaw Nation to arbitrate a dispute over prescription drug reimbursement with CVS Health Corp. subsidiaries, affirming an Arizona federal judge's order in a published opinion Monday.

  • June 10, 2024

    'Four Tops' Singer Sues ER Staff Who Ordered Psych Test

    The lead singer of Motown group The Four Tops has sued a hospital in Michigan federal court, claiming in a complaint filed Monday that hospital staff treated him as if he was mentally ill when he said he was a famous singer.

  • June 10, 2024

    Live Urgent Care In-House Atty Axed For Pregnancy, Suit Says

    A former in-house attorney and compliance officer for Live Urgent Care LLC alleged in New Jersey state court on Friday that she was fired in retaliation for asking to take maternity leave and demanding a bonus she claims was never paid.

  • June 10, 2024

    Medical-Aesthetic Device Rivals Set For Sept. Poaching Trial

    A Boston federal judge on Monday scheduled a post-Labor Day jury trial for medical-aesthetic device company Cynosure's $78 million poaching lawsuit against rival Reveal Lasers, urging the parties to streamline their exhibits and damages claims.

  • June 07, 2024

    Motley Rice Allocated Biggest Share Of $2B Opioid Fees

    A panel directed with allocating $2.13 billion in attorney fees stemming from opioid settlements has recommended awarding the largest shares of the pot to Motley Rice LLC, Simmons Hanly Conroy LLC and Napoli Shkolnik PLLC, according to a report filed Friday in Ohio federal court.

  • June 07, 2024

    Speech Pathologists Say BakerHostetler Bungled Biz Deal

    A trio of Los Angeles-based speech pathologists have filed a malpractice suit against their former BakerHostetler counsel in California state court, accusing the firm and an Ohio-based partner of negligence in failing to properly advise them amid a business deal, allegedly resulting in the therapists losing their successful practice and more than $1 million.

  • June 07, 2024

    Bank Says Alzheimer's Center Owes $17M On Defaulted Loan

    An Alzheimer's care center owes Bank of Oklahoma nearly $17 million after it became the last of four memory care facilities to default on a $27.5 million loan that was used to refinance their mortgage debt, according to a complaint filed in Georgia federal court.

  • June 06, 2024

    White Collar Boutique Sued By Ex-Client Over Representation

    White collar boutique Clark Smith Villazor LLP and one of its name partners is facing a lawsuit from a former client, a convicted securities fraud defendant who claims the firm caused him to be arrested by the FBI and face millions of dollars in fines.

  • June 06, 2024

    Drugmakers Escape Cancer Drug Antitrust Claims For Now

    A New Jersey federal judge granted drugmakers Celgene and Bristol-Myers Squibb an out from consolidated antitrust litigation accusing them of delaying generic competition to their blockbuster cancer treatments, saying the conduct alleged by a group of insurer plaintiffs fails to amount to anti-competitive conduct.

  • June 06, 2024

    Wash. Judge Suggests Insurer Dragged Out IP Dispute

    A Washington federal judge appeared unconvinced Thursday by a dental health insurer's argument that it acted honestly in pushing forward with trade secret claims even after the accused ex-employee returned her company-issued laptop that purportedly held sensitive information.

  • June 06, 2024

    Insurer Off The Hook For $3.4M Nursing Home Death Verdict

    A Berkshire Hathaway unit needn't cover a $3.4 million default judgment entered against its insured in a wrongful death suit, an Illinois federal judge determined, finding that the insured nursing home "did not meet its own reporting and cooperation obligations under the policy."

  • June 06, 2024

    8th Circ. Affirms Cigna Noncompete Applies To CVS Hire

    The Eighth Circuit has backed a lower court finding that blocked a healthcare industry executive from making a move to CVS, handing a win to Cigna in a case over trade secrets.

  • June 06, 2024

    9th Circ. Tells Insurer To Cover Teen's Treatment Center Stay

    The Ninth Circuit has upheld a Massachusetts mother's win in her fight to get her insurer to cover behavioral health treatment for her son, ruling Thursday that a Washington federal judge was correct to order the insurer to cover her son's 14-month stay in a residential treatment center.

  • June 05, 2024

    Medtronic Can't Pause FCA Claims For 1st Circ. Detour

    A Massachusetts federal judge on Wednesday declined to pause a long-pending False Claims Act and whistleblower retaliation case against medical device maker Medtronic so it can appeal a recent ruling, saying the court and the parties need to "get it moving."

  • June 04, 2024

    Biotech RenovaCare Can't Beat Investors' Stock Promo Suit

    A New Jersey federal judge has ruled that investors in biotechnology company RenovaCare Inc. failed to prove their case against firms they accused of profiting from a scheme to pump up the company's shares, but otherwise allowed their claims to proceed against the maker of skin burn treatments and a few of its executives.

  • June 04, 2024

    Pharma Cos. Tell Justices Feds Support Remanding Terror Suit

    Pharmaceutical companies urged the U.S. Supreme Court on Tuesday to heed the federal government's suggestion to throw out a D.C. Circuit ruling holding them potentially liable for allegedly financing terror attacks against U.S. servicemembers through contracts with the Iraqi government.

  • June 04, 2024

    Nurse Staffing Exec Wants Antitrust, Fraud Charges Separated

    An indicted home health care staffing executive asked a Nevada federal court to separate the antitrust charge against him for allegedly fixing nurses wages from claims that he concealed the conspiracy and government probe when selling the business for more than $10 million.

  • June 04, 2024

    Fox Rothschild Partner Can't Testify In NJ Fraud Retrial

    Fox Rothschild LLP partner Ernest E. Badway can't serve as an expert witness for a businessman facing retrial on securities fraud claims, a New Jersey federal judge ruled Tuesday, siding with the government's contention that the testimony would be irrelevant.

  • June 03, 2024

    Humana Hit With Investor Suit Over Post-COVID Costs

    Health insurer Humana and two executives were hit with an investor class action on Monday, claiming they misled shareholders about the cost of pent-up demand for medical treatments once the COVID-19 pandemic subsided.

  • May 31, 2024

    9th Circ. Affirms Toss Of Health Center's $8M Cigna Row

    The Ninth Circuit on Friday declined to revive a suit from a holding company for a drug and alcohol treatment center claiming Cigna forced it into bankruptcy by not paying more than $8 million in authorized claims, finding the health insurer did not abuse its discretion in denying the payments.

  • May 31, 2024

    Co. Renews Dispute Over $1B CMS IT Deal At Claims Court

    An information technology services firm has protested the Centers for Medicare and Medicaid Services' corrective action on a $1 billion IT deal, saying the agency didn't meaningfully reevaluate proposals, seeking only to shore up its previous awards.

  • May 31, 2024

    COVID Test Contract Suit 'Cries Out' For Jury, NC Judge Says

    A fight between two companies over a doomed distribution deal for COVID-19 tests has gone from "ships passing in the night" to not even "sailing in the same ocean," a North Carolina Business Court judge said, paring the case for trial.

  • May 31, 2024

    Ex-Penn State Football Team Doc Wins $5.25M Retaliation Suit

    A Pennsylvania jury awarded $5.25 million to a former doctor for the Pennsylvania State University football team who claimed he was fired for reporting that head coach James Franklin pressured him to push student-athletes back onto the field before they were ready, according to a verdict sheet made public Friday.

Expert Analysis

  • Bracing For Regulatory Delays As Shutdown Looms

    Author Photo

    As a government shutdown looms, stakeholders should plan for regulatory delays and note that more regulations could become vulnerable to congressional disapproval under the Congressional Review Act, say Matthew Shapanka and Holly Fechner at Covington.

  • How A Gov't Shutdown Would Affect Immigration Processing

    Author Photo

    While a government shutdown would certainly create issues and cause delays for immigration processing, independently funded functions would continue for at least a limited time, and immigration practitioners can expect agencies to create reasonable exceptions and provide guidance for navigating affected matters once operations resume, say William Stock and Sarah Holler at Klasko Immigration Law Partners.

  • Smart Immigration Reform Can Improve Health Care Access

    Author Photo

    With the U.S. health care crisis expected to worsen due to ongoing nationwide physician shortages, immigration reform can provide one short-term solution to bring more trained doctors to medically underserved areas, says Sarah Peterson at Fragomen.

  • HIV Drug Case Against Gilead Threatens Medical Innovation

    Author Photo

    The California Court of Appeals should dismiss claims alleging that Gilead should be held liable for not bringing an HIV treatment to market sooner, or else the biopharmaceutical industry could be disincentivized from important development and innovation, says James Stansel at Pharmaceutical Research and Manufacturers of America.

  • Developers Are Testing Defenses In Generative AI Litigation

    Author Photo

    In the rapidly growing field of generative artificial intelligence law in the U.S., there are a few possible defenses that have already been effectively asserted by defendants in litigation, including lack of standing, reliance on the fair use doctrine, and the legality of so-called data scraping, say attorneys at K&L Gates.

  • How Calif. Ruling Extends Worker Bias Liability To 3rd Parties

    Author Photo

    The California Supreme Court's recent significant decision in Raines v. U.S. Healthworks Medical Group means businesses that provide employment-related services to California employers can potentially be held liable for California’s Fair Employment and Housing Act violations, says Ryan Larocca at CDF Labor.

  • Laws Based On Rapid Drug Tests Are Unscientific And Unfair

    Author Photo

    Given the widespread legalization of marijuana, states are increasingly implementing laws to penalize drivers under the influence of drugs, but the laws do more harm than good as the rapid tests they rely on do not accurately measure impairment, say Josh Bloom and Henry Miller at the American Council on Science and Health.

  • 9th Circ.'s Latest UBH Ruling Ignores Case's Core Issue

    Author Photo

    The Ninth Circuit’s recent decision to vacate its earlier opinion in Wit v. United Behavioral Health frustratingly disregards the case’s key issue of benefits coverage for mental health treatment, and illogically elevates an insurer's discretionary authority over the medically necessary needs of patients, says Mark DeBofsky at DeBofsky Law.

  • A New Strategy For Defending Spine Injury Claims

    Author Photo

    With spinal injury claims proliferating — often with verdicts in the seven-figure range — defense counsel can expand their current trial playbook by retaining experts to prepare and publish peer-reviewed scientific studies that can then be used in the courtroom to help juries understand the issues, says Nicholas Hurzeler at Lewis Brisbois.

  • Purdue Ch. 11 Case Exemplifies Need For 3rd-Party Releases

    Author Photo

    In the Purdue Pharma Chapter 11 case, the U.S. Supreme Court will eventually decide whether the Bankruptcy Code authorizes a court to approve third-party releases, but removing this powerful tool would be a significant blow to the likelihood of future victims being made whole, says Isaac Marcushamer at DGIM Law.

  • 2023 Farm Bill Could Follow Md., Minn. Or NY's Lead On Hemp

    Author Photo

    As potential changes to federal hemp policy are hammered out in the 2023 Farm Bill, lawmakers may look to recent regulations promulgated in Maryland, Minnesota and New York, which provide several possible regulatory frameworks for hemp and synthetic cannabinoids, say Seth Gitner and Jonathan Havens at Saul Ewing.

  • What Cos. Should Know About Software Development Kits

    Author Photo

    Tracking technologies such as software development kits have recently become the focus of regulatory action and litigation, and companies should consider taking steps to reduce associated risks, such as evaluating services and establishing a governance framework, say Daniel Goldberg and Rick Borden at Frankfurt Kurnit.

  • Conn. Ruling Highlights Keys To Certificate-Of-Need Appeals

    Author Photo

    The Connecticut Supreme Court's recent decision in High Watch Recovery Center v. Department of Public Health, rejecting rigid application of statutes concerning certificate-of-need procedure, provides important guidance on building an administrative record to support a finding that a case is contested, say attorneys at Robinson & Cole.

Can't find the article you're looking for? Click here to search the Healthcare Authority Other archive.